Recombination of Globally Circulating Varicella-Zoster Virus

被引:58
作者
Norberg, Peter [1 ]
Depledge, Daniel P. [2 ]
Kundu, Samit [2 ]
Atkinson, Claire [3 ]
Brown, Julianne [4 ]
Haque, Tanzina [3 ]
Hussaini, Yusuf [5 ]
MacMahon, Eithne [6 ]
Molyneaux, Pamela [7 ]
Papaevangelou, Vassiliki [8 ]
Sengupta, Nitu [9 ]
Koay, Evelyn S. C. [10 ]
Tang, Julian W. [11 ]
Underhill, Gillian S. [12 ]
Grahn, Anna [1 ]
Studahl, Marie [1 ]
Breuer, Judith [2 ]
Bergstrom, Tomas [1 ]
机构
[1] Univ Gothenburg, Dept Infect Dis, Sect Clin Virol, Inst Biomed, Gothenburg, Sweden
[2] MRC, Ctr Med Mol Virol, Div Infect & Immun, London, England
[3] Royal Free Hosp, Dept Virol, London NW3 2QG, England
[4] Great Ormond St Hosp Children NHS Fdn Trust, Camelia Botnar Labs, Microbiol Virol & Infect Prevent & Control, London, England
[5] Ahmadu Bello Univ, Dept Microbiol, Zaria, Kaduna State, Nigeria
[6] Guys & St Thomas NHS Fdn Trust, St Thomas Hosp, Dept Infect Dis, London, England
[7] Aberdeen Royal Infirm, Dept Med Microbiol, Aberdeen, Scotland
[8] Univ Athens, Sch Med, Univ Gen Hosp ATTIKON, Dept Pediat 3, GR-11527 Athens, Greece
[9] Ealing Serv Children Addit Needs, London, England
[10] Natl Univ Singapore Hosp, Mol Diag Ctr, Dept Lab Med, Singapore 117548, Singapore
[11] Univ Hosp Leicester NHS Trust, Clin Microbiol, Leicester, Leics, England
[12] Queen Alexandra Hosp, Dept Clin Microbiol, Portsmouth, Hants, England
基金
英国医学研究理事会;
关键词
INFECTIOUS LARYNGOTRACHEITIS; PHYLOGENETIC ANALYSIS; GENETIC-RECOMBINATION; ATTENUATED VACCINES; HERPES-ZOSTER; DNA-SEQUENCE; GENOTYPES; STRAINS; EPIDEMIOLOGY; DIVERSITY;
D O I
10.1128/JVI.00437-15
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Varicella-zoster virus (VZV) is a human herpesvirus, which during primary infection typically causes varicella (chicken pox) and establishes lifelong latency in sensory and autonomic ganglia. Later in life, the virus may reactivate to cause herpes zoster (HZ; also known as shingles). To prevent these diseases, a live-attenuated heterogeneous vaccine preparation, vOka, is used routinely in many countries worldwide. Recent studies of another alphaherpesvirus, infectious laryngotracheitis virus, demonstrate that live-attenuated vaccine strains can recombine in vivo, creating virulent progeny. These findings raised concerns about using attenuated herpesvirus vaccines under conditions that favor recombination. To investigate whether VZV may undergo recombination, which is a prerequisite for VZV vaccination to create such conditions, we here analyzed 115 complete VZV genomes. Our results demonstrate that recombination occurs frequently for VZV. It thus seems that VZV is fully capable of recombination if given the opportunity, which may have important implications for continued VZV vaccination. Although no interclade vaccine-wild-type recombinant strains were found, intraclade recombinants were frequently detected in clade 2, which harbors the vaccine strains, suggesting that the vaccine strains have already been involved in recombination events, either in vivo or in vitro during passages in cell culture. Finally, previous partial and complete genomic studies have described strains that do not cluster phylogenetically to any of the five established clades. The additional VZV strains sequenced here, in combination with those previously published, have enabled us to formally define a novel sixth VZV clade. IMPORTANCE Although genetic recombination has been demonstrated to frequently occur for other human alphaherpesviruses, herpes simplex viruses 1 and 2, only a few ancient and isolated recent recombination events have hitherto been demonstrated for VZV. In the present study, we demonstrate that VZV also frequently undergoes genetic recombination, including strains belonging to the clade containing the vOKA strain.
引用
收藏
页码:7133 / 7146
页数:14
相关论文
共 50 条
  • [41] Clinical Manifestations and Outcomes of Varicella-zoster Virus Endotheliitis
    Cho, Yong Wun
    Lee, Dong Woo
    Kim, Gyu Nam
    Kim, Hyun-A
    Kim, Seong-Jae
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2019, 60 (12): : 1162 - 1168
  • [42] The Spectrum of Neurological Manifestations of Varicella-Zoster Virus Reactivation
    Kennedy, Peter G. E.
    VIRUSES-BASEL, 2023, 15 (08):
  • [43] Neuro-ophthalmic complications of varicella-zoster virus
    Tofade, Toluwalase O.
    Chwalisz, Bart K.
    CURRENT OPINION IN OPHTHALMOLOGY, 2023, 34 (06) : 470 - 475
  • [44] Monitoring prevalence of varicella-zoster virus clades in Germany
    Sauerbrei, A.
    Stefanski, J.
    Philipps, A.
    Krumbholz, A.
    Zell, R.
    Wutzler, P.
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2011, 200 (02) : 99 - 107
  • [45] Current In Vivo Models of Varicella-Zoster Virus Neurotropism
    Mahalingam, Ravi
    Gershon, Anne
    Gershon, Michael
    Cohen, Jeffrey I.
    Arvin, Ann
    Zerboni, Leigh
    Zhu, Hua
    Gray, Wayne
    Messaoudi, Ilhem
    Traina-Dorge, Vicki
    VIRUSES-BASEL, 2019, 11 (06):
  • [46] Clinicopathologic understanding and control of varicella-zoster virus infection
    Asano, Yoshizo
    VACCINE, 2008, 26 (50) : 6487 - 6490
  • [47] Neurological complications of varicella-zoster virus infection in children
    Fraszczak, Justyna
    Mania, Anna
    Kemnitz, Pawel
    Mazur-Melewska, Katarzyna
    Figlerowicz, Magdalena
    AKTUALNOSCI NEUROLOGICZNE, 2021, 21 (04): : 231 - 237
  • [48] Varicella-zoster virus: An overlooked cause of aseptic meningitis
    Jhaveri, R
    Sankar, R
    Yazdani, S
    Cherry, JD
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (01) : 96 - 97
  • [49] Varicella-zoster virus infection of the central nervous system
    Alarcon Garcelan, Maria Carmen
    Luque Marquez, Rafael
    Merino Diaz, Laura
    Rodriguez Torres, Patricia
    MEDICINA CLINICA, 2014, 143 (01): : 45 - 46
  • [50] Varicella-zoster virus encephalomyelitis with a prominent demyelinating component
    Berth, Sarah
    Carbunar, Olimpia
    Yang, Ning Sarah
    Fredericks, Brian
    Lipton, Howard L.
    Valyi-Nagy, Tibor
    NEUROPATHOLOGY, 2015, 35 (06) : 587 - 591